Key result
HRV biofeedback may reduce CV risk in depression by increasing parasympathetic input.
Why the study?
Depression treatments can enhance cardiovascular risk by negatively impacting autonomic balance, but heart rate variability biofeedback may increase parasympathetic input.
Does Heart rate variability biofeedback (HRV BFB) training reduce cardiovascular risk and improve symptoms in patients with depression?
Does Heart rate variability biofeedback (HRV BFB) training reduce cardiovascular risk and improve symptoms in patients with depression?
Heart rate variability biofeedback may serve as a useful adjunctive treatment to improve autonomic balance and reduce cardiovascular risk in patients with depression.
May support adjunctive HRV biofeedback in depression; leaves open prospective RCTs for cardiovascular outcomes.
Several interventions used in treatment of depressive symptoms can enhance cardiovascular risk due to negative impacts on autonomic balance. Decreased vagal tone and/or excessive sympathetic nervous system activity have been noted in patients with depression. Heart rate variability biofeedback (HRV BFB) training may be able to reduce the cardiovascular risk for depressed patients by increasing the parasympathetic input to the heart. The results of published studies support that HRV BFB may be useful as an adjunctive treatment for patients with depression.
No takes yet. Share an insight, caveat, or question.
Marcin Kopka (2023) conducted a review in Depression. Heart rate variability biofeedback (HRV BFB) was evaluated. Heart rate variability biofeedback may be useful as an adjunctive treatment for patients with depression to reduce cardiovascular risk by increasing parasympathetic input to the heart.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: